Cubist Pharmaceuticals (NASDAQ:CBST)

462542665

Jefferies Stocks to Buy That Could Jump From an Earnings Surprise

The extreme market volatility of the past few weeks has left some investors very nervous. Ongoing selling of technology (Internet) and biotech shares spilled over into the broad market during ...
Read Full Story »
DNA

Ten Top Biotech Merger and Partnership Candidates

One of the ways the big pharmaceutical and biotechnology firms grow their business is through partnerships and acquisitions. That was never more in focus than Thursday when Pfizer lost its ...
Read Full Story »
biotech

Jefferies Top Biotech Stocks to Buy

The world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not change all that much, the manner in which it can ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Anadarko, Cubist, K12, EOG and More

Earnings season has just started, and investors and traders alike are having to face a government shutdown and a debt ceiling debate painfully developing each day. So which companies and ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Baidu, Cubist, Whole Foods and More

Stocks have seen five days of selling, and investors are deciding which stocks are bargains and which ones will have more downside. 24/7 Wall St. reviews dozens of Wall Street ...
Read Full Story »
biotech

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Even though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive on large cap biotechnology names. Acknowledging in their recent report ...
Read Full Story »
biotech

PropThink Biotech Stocks With Big Upside Potential

The world of biotech investing is always a difficult one. Often a binary event, such as a U.S. Food and Drug Administration (FDA) approval or a life-saving capital raise is ...
Read Full Story »
Bull and Bear figures

Closing Bell for Friday on Wall Street: Markets Open Lower, Fail to Break Out

U.S. equity markets opened sharply lower again this morning, but this time reacting to yesterday’s comments by Fed Chairman Ben Bernanke that the Fed could slow its bond purchases in ...
Read Full Story »
Bull and Bear

Top 10 Analyst Upgrades and Downgrades: Cubist, Marvell, PG and More

Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall ...
Read Full Story »
biotech

PropThink Biotech Stocks to Buy with Big Gains: Cubist, Immunomedics and More

The world of biotech investing is always a difficult one. Often a binary event, such as U.S. Food and Drug Administration (FDA) approval or a life-saving capital raise, is the ...
Read Full Story »
Wall St Bull statue

Top Analyst Upgrades and Stocks to Buy: Aetna, Sony, ICE, Cubist and More

Investors and traders seem to be constantly looking for fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each ...
Read Full Story »
biotech

Top New Biotech Ideas From PropThink

The world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA) approval or a life-saving capital raise is the ...
Read Full Story »
Wall St Bull statue

Top Wall Street Analyst Upgrades: AllState, Cubist, Beazer and More

Investors and traders are constantly looking for fresh research ideas from Wall Street that will lead to higher income or more profits. We review many fresh research calls to find ...
Read Full Story »
Bull and Bear figures

24/7 Wall St. Closing Bell — April 3, 2013: Markets Skid on Jobs and Oil Reports (CBST, CRL, GFI, NEE, CAT, TISI, CAG, MON, SCHN, DDC, GBX, RPM, ZNGA, BAC, FB)

U.S. equity markets opened very slightly higher this morning but it was all downhill from there. The U.S. jobs report from ADP came in weaker than expected and cast a ...
Read Full Story »
Bull and Bear

Top 12 Analyst Upgrades and Downgrades (AU, APO, ASTX, ATML, BSX, CAT, FUN, CRL, CI, CBST, DUK, EMC, GFI, NEE, PNRA, SIX, TUMI, TCB, XEL)

Investors and traders generally stay on the lookout for new ideas that will generate positive returns or income for their portfolio. 24/7 Wall St. looks over numerous research calls to ...
Read Full Story »